ArticleClinical and experimental immunology1998

Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells.

M A Frassanito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.